Eugene Marcantonio
Directeur Général chez ARMGO Pharma, Inc.
Postes actifs de Eugene Marcantonio
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
ARMGO Pharma, Inc.
 ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | Directeur/Membre du Conseil | 01/10/2017 | - |
| Directeur Général | 01/01/2021 | - | |
| Directeur Technique/Scientifique/R&D | 01/04/2017 | 01/01/2021 | |
| President | 01/04/2017 | 01/01/2021 |
Historique de carrière de Eugene Marcantonio
Formation de Eugene Marcantonio
| New York University School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
ARMGO Pharma, Inc.
ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | Health Technology |
- Bourse
- Insiders
- Eugene Marcantonio
- Expérience
